Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension
Status:
Completed
Trial end date:
2018-09-17
Target enrollment:
Participant gender:
Summary
This open label 4 month study will evaluate efficacy (blood pressure lowering effects) and
safety of lisinopril in children 1-18y whose parents grant permission to participate. This
dose titration study is being conducted to support the statement that personalized titration
of lisinopril (based on blood pressure and renin-aldosterone ratio) can increase patient
response.